SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: Strong Long who wrote (1795)3/29/2016 7:27:46 PM
From: phoenix_rising  Respond to of 2026
 
I don't see why LUTS would be viable when APRI have shelved the drug now and if the P2B had been good, LUTS was the next indication to go for. As SB would say "Fis is DEAD"....only he would say it 3 times a day for 2 weeks!



To: Strong Long who wrote (1795)3/29/2016 10:41:57 PM
From: eico20  Respond to of 2026
 
SL, it's clear that Apri is letting Fis go, if Forendo wants to do something it appears they can, but it was very clear in the press release and conf call that Apri is moving on without any further investment in Fis., if Fis had shown stronger results with raising T levels I think they would have pursued another indication, but it seemed all 3 endpoints were insufficient, Vitaros is the only near term hope at this point and it's been very slow going so far.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News